Imaging Biomarkers for Immune Checkpoint Inhibitor Treatment in Patients With Non-small Cell Lung Cancer

Clinical trial NCT05260606 · UNKNOWN

Trial details

NCT number: NCT05260606
Sponsor: Samsung Medical Center
Status: UNKNOWN
Study type: OBSERVATIONAL

Carcinoma, Non-Small-Cell Lung Immune Checkpoint Inhibitors

Start date: 2022-05-09
Primary completion: 2025-12-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.